Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 602-927-1 | CAS number: 123312-89-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2 Jul 1991 to 12 Aug 1991
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- Adopted May 1983
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- 1984
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EPA OTS 798.5265 (The Salmonella typhimurium Bacterial Reverse Mutation Test)
- Version / remarks:
- 1987
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: THE MINISTRY OF HEALTH AND WELFARE, Japan , Guidelines of Toxicity Studies Required for Applications for Approval to Manufacture (Import) Drugs (Part 1), Notification No. 118 of the Pharmaceutical Affairs Bureau, Ministry of Health and Welfare.
- Version / remarks:
- 1984
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 6-methyl-4-[(E)-[(pyridin-3-yl)methylidene]amino]-2,3,4,5-tetrahydro-1,2,4-triazin-3-one
- EC Number:
- 602-927-1
- Cas Number:
- 123312-89-0
- Molecular formula:
- C10H11N5O
- IUPAC Name:
- 6-methyl-4-[(E)-[(pyridin-3-yl)methylidene]amino]-2,3,4,5-tetrahydro-1,2,4-triazin-3-one
- Test material form:
- solid: particulate/powder
Constituent 1
Method
- Target gene:
- his- (S. typhimurium), trp- (E. coli)
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced rat liver S9 mix
- Test concentrations with justification for top dose:
- Range in the (preliminary) cytotoxicity test (with and without microsomal activation): 20.6, 61.7, 185, 555, 1666 and 5000 μg/plate
Range in the mutagenicity test (with and without microsomal activation): 312, 625, 1250, 2500 and 5000 μg/plate
Justification for top dose: 5000 μg/plate is the maximum recommended dose according to the test guideline - Vehicle / solvent:
- Dimethylsulfoxide (DMSO)
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- cyclophosphamide
- other: 2-Aminoanthracene (2-AA); 4-Nitroquinoline (4-NQ)
- Details on test system and experimental conditions:
- PRELIMINARY CYTOTOXICITY ASSAY: A preliminary toxicity test was carried out with strains s. typhimurium TA 100 and E.coli WP2uvrA with and without microsomal activation at six concentrations of the test substance and one negative control according to Standard Operating Procedures of Genetic Toxicology. The highest concentration applied was the highest applicable concentration (due to the solubility limit of the test substance in the solvent) or 5000 μg/plate. The five lower concentrations decreased by a factor of 3 (The number of concentrations tested and the factor of dilution were in deviation to the SOP effective at the time of this study). The plates were inverted and incubated for about 48 hours at 37 ± 1.5 °C in darkness. Thereafter, they were evaluated by counting the colonies and determining the background lawn. One plate per test substance concentration, as well as each negative control was used.
METHOD OF APPLICATION: in agar (plate incorporation)
PROTOCOL
- Inoculates from frozen master copies were set up monthly. They were grown in liquid NB-medium overnight and then plated on NB-agar. After incubation, single colonies were taken from the plates, grown overnight in liquid NB-medium and then used for the experiment.
- 0.1 mL of the overnight cultures were mixed with 2 ml of top agar, either 0.5 mL of 100 mM sodium phosphate buffer (experiments without activation) or 0.5 mL of the activation mixture (experiments with activation) and 0.1 mL of a solution of the test substance, the substance for the positive control or the solvent for the negative control and poured on minimal agar in Petri dishes. Each Petri dish contained about 20 mL of minimal agar (1.5% agar supplemented with 2% salts of the Vogel-Bonner Medium E and 2% glucose). The top agar was composed of 0.6% agar and 0.6% NaCl. In the experiment with Salmonella the top agar was supplemented with 10% of 0.5 mM L-histidine and 0.5 mM (+)biotin dissolved in water. In the experiment with E. coli it was supplemented with 10% of 0.5 mM L-tryptophan dissolved in water.
- The mutagenicity test was performed with the Salmonella typhimurium strains TA 98, TA 100, TA 1535 and TA 1537 and with the Escherichia coli strain WP2uvrA without and with microsomal activation according to Standard Operating Procedures of Genetic Toxicology. Each of the five concentrations of the test substance (312 to 5000 μg/plate), a negative and a positive control were tested, using three plates per test substance concentration as well as each positive and negative control with each tester strain. The highest concentration applied was determined in the preliminary toxicity test and the four lower concentrations were each decreased by a factor of 2. The plates were inverted and incubated for about 48 hours at 37 ± 1.5°C in darkness. Thereafter, they were evaluated by counting the number of colonies and determining the background lawn.
- Colonies were counted electronically with an Artek counter. The results were sent online to a computer. They were checked on a random basis by the operator. Observations indicating precipitates of the test substance in the top agar or a reduced or absent bacterial background lawn were registered additionally. Means and standard deviations for all mutagenicity assays were calculated by a previously validated computer program. - Evaluation criteria:
- ASSAY ACCEPTANCE CRITERIA:
A test is considered acceptable if the mean colony counts of the control values of all strains are within the acceptable ranges and if the results of the positive controls meet the criteria for a positive response. In either case the final decision is based on the scientific judgement of the Study Director
CRITERIA FOR A POSITIVE RESPONSE:
The test substance is considered to be mutagenic in this test system if one or both of the following conditions are met:
- At least a reproducible doubling of the mean number of revertants per plate above that of the negative control at any concentration for one or more of the following strains: s. typhimurium TA 98, TA 1535, TA 1537 and E. Coli WPuvrA.
-A reproducible increase of the mean number of revertants per plate for any concentration above that of the negative control by at least a factor of 1.5 for strains. typhimurium TA 100.
- Generally a concentration-related effect should be demonstrable - Statistics:
- None.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium, other: TA1537, TA1535, TA100, TA98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: At the concentrations of 50 and 25 mg/mL precipitates were visible. The highest concentration soluble in dimethylsulfoxide was found to be 12.5 mg/mL. The highest concentration tested was 5 mg/mL.
RANGE-FINDING/SCREENING STUDIES:
Six concentrations of the test substance ranging from 20.6 to 5000 μg/plate were tested with strains S. typhimurium TA 100 and E.coli WP2uvrA to determine the highest concentration to be used in the mutagenicity assay. The experiments were performed with and without microsomal activation. From the results obtained, the highest concentration suitable for the mutagenicity test was selected to be 5000 μg/plate without activation and 5000 μg/plate with activation.
NUMBER OF CELLS WITH REVERSE MUTATION
In the original experiment performed without and with microsomal activation, none of the tested concentrations led to an increase in the incidence of either histidine- or tryptophan-prototrophic mutants by comparison with the negative control. In the confirmatory experiment performed without and with microsomal activation, again, the tested concentrations did not lead to an increase in the incidence of either histidine- or tryptophan-prototrophic mutants by comparison with the negative control.
HISTORICAL CONTROL DATA
- Positive and negative historical control data can be found in Table 1 and 2 in ‘any other information on results incl. tables’. The data is presented as Arithmetic Mean (m) and Standard Deviation (s) of colony counts obtained in 91 separate experiments over the period of January 15, 1990 to January 02, 1991. Acceptable range for mean colony counts (=mean of values) of spontaneous revertants.
Any other information on results incl. tables
Table 1. Historical data positive and negative control in absence of metabolic activation.
Strain |
Substance |
µg/plate |
Mean |
StDev |
Acceptable range |
TA 100 |
Negative control |
|
146.9 |
28.2 |
8-220 |
|
sodium azide |
2.0 |
762.9 |
257.2 |
|
TA 1535 |
Negative control |
|
11.4 |
3.3 |
7-30 |
|
sodium azide |
2.0 |
699.4 |
277.8 |
|
E. Colie WP2uvrA |
Negative control |
|
20.2 |
4.5 |
8-40 |
|
4-nitroquinoline-N-oxide |
1.0 |
501.7 |
323.4 |
|
TA 98 |
Negative control |
|
19.1 |
4.4 |
12-50 |
|
2-nitrofluorene |
10.0 |
1287.5 |
308.9 |
|
TA 1537 |
Negative control |
|
7.9 |
2.6 |
3-20 |
|
9-amino acridine |
150.0 |
2158.9 |
583.3 |
|
Table 2. Historical data positive and negative control in presence of metabolic activation.
Strain |
Substance |
µg/plate |
Mean |
StDev |
Acceptable range |
TA 100 |
Negative control |
|
142.2 |
25.8 |
70-220 |
|
2-aminoanthracene |
2.5 |
1768.8 |
544.2 |
|
TA 1535 |
Negative control |
|
12.6 |
3.2 |
7-35 |
|
Cyclophosphamide |
400.0 |
349.6 |
126.1 |
|
E. Colie WP2uvrA |
Negative control |
|
22.3 |
5.2 |
8-50 |
|
2-aminoanthracene |
50.0 |
1109.7 |
277.1 |
|
TA 98 |
Negative control |
|
35.4 |
5.7 |
20-70 |
|
2-aminoanthracene |
2.5 |
1759.9 |
470.3 |
|
TA 1537 |
Negative control |
|
12.0 |
4.3 |
5-30 |
|
2-aminoanthracene |
5.0 |
204.3 |
82.4 |
|
Applicant's summary and conclusion
- Conclusions:
- In this GLP compliant study, performed according to OECD 471, the test substance and its metabolites did not induce gene mutations in the tested strains of S. typhimurium and E. coli
- Executive summary:
In this GLP compliant OECD 471 study (a reverse gene mutation assay in bacteria), the test substance in dimethylsulphoxide (DMSO) was tested on four histidine-auxotrophic strains (TA98, TA100, TA1535 and TA1537) of Salmonella typhimurium and on the tryptophan-auxotrophic strain WP2uvrA of Escherichia coli, by plate incorporation, at concentrations of 0 (solvent control), 312.5, 625, 1250, 2500 and 5000 µg/plate. Two independent assays were performed, both experiments with and without S9 metabolic activation (S9 fraction from Arochlor 1254 induced rat liver). After preparation, the plates were inverted and incubated for about 48 hours at 37±1.5°C and evaluated by colony counting with an Artek counter and determining the background lawn. Concurrent strain-specific mutagens were applied to all strains as positive controls in both experiments. In the range finding test, normal background growth occurred with both strains, with or without metabolic activation and no appreciable cytotoxicity was observed at 5000 µg/plate, the highest concentration evaluated. In the main study, the test substance did not increase the number of revertants in any of the strains used, with or without metabolic activation, in either experiment when compared to the vehicle controls. There was no evidence of toxicity to the bacteria at any concentration, in either experiment. The positive controls produced a marked increase of the number of revertant colonies. Therefore, it was concluded that the test substance and its metabolites did not induce gene mutations in the strains of S. typhimurium and E. coli used in the study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.